SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-033540
Filing Date
2022-11-23
Accepted
2022-11-23 16:05:28
Documents
12
Period of Report
2022-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34483
  Complete submission text file 0001493152-22-033540.txt   204158

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocx-20221119.xsd EX-101.SCH 3224
3 XBRL LABEL FILE ocx-20221119_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocx-20221119_pre.xml EX-101.PRE 22358
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3461
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 221416348
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences